Ratnakar Securities Pvt. Ltd.

STRIDES PHARMA SCIENCE LTD.

NSE : STARBSE : 532531ISIN CODE : INE939A01011Industry : Pharmaceuticals & DrugsHouse : Private

BSE792.052.3 (+0.29 %)

PREV CLOSE ( ) 789.75

OPEN PRICE ( ) 804.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 8513

TODAY'S LOW / HIGH ( )781.25 804.95

52 WK LOW / HIGH ( )530.7 1675.25

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 28-06 1990

Management Info

Arun Kumar - Chairman Badree Komandur - Managing Director

Registered Office

Address Cyberone, Unit No. 902,Plot No - 4 & 6,Sector 30 A, Vashi,
Navi Mumbai,
Maharashtra-400703

Phone 022-27892924 / 3199

Email corpcomm@strides.com

Website www.strides.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

10May Strides Pharma Science informs about
Strides Pharma Science has informed that it enclosed the certain changes..

30Apr Strides Pharma Scienceâ€™s arm acquire
Strides Pharma Scienceâ€™s step-down wholly owned subsidiary -- Strides..

30Apr Strides Pharma Science shines as its a
Strides Pharma Science is currently trading at Rs. 670.25, up by 17.70 p..

11Apr Strides Pharma Science's arm incorpora
Strides Pharma Science's a wholly owned subsidiary -- Arco Lab has incor..

11Apr Strides Pharma Science zooms as its ar
Strides Pharma Science is currently trading at Rs. 611.40, up by 27.35 p..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	161.280000000001	28862.11
Gross Profit	283.230000000001	780.829999999999
Operating Profit	800.540000000001	3086.3
Net Sales	5559.58	21394.23

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE) 31282.70 (0.71%)	M.Cap ( in Cr)66297.82
Glaxosmithkline Phar (BSE) 3427.35 (6.32%)	M.Cap ( in Cr)58061.38
Astrazeneca Pharma I (BSE) 9487.50 (1.64%)	M.Cap ( in Cr)23718.75
Jenburkt Pharma (BSE) 1294.60 (13.22%)	M.Cap ( in Cr)571.35
Divi's Lab (BSE) 6617.45 (1.34%)	M.Cap ( in Cr)175342.00

Shareholding Pattern

	MUTUAL FUNDS/UTI	8.89%
	FI/BANKS/INSURANCE	3.03%
	NON-INSTITUTION	29.65%
	PROMOTERS	28.3%
	GOVERNMENT	0.01%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
JM Small Cap Fund-Reg(G)	1.70
JM ELSS Tax Saver Fund(G)	1.40
Quant Business Cycl...	1.16
WOC Pharma and Heal...	1.09
Quant Active Fund(G)	1.01
Quant Small Cap Fund(G)	0.90

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

STRIDES PHARMA SCIENCE LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES